Alyeska Investment Group
QTTB icon

Alyeska Investment Group’s Q32 Bio QTTB Stock Holding History

Alyeska Investment Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,333
Closed -$1.09M – 815
2021
Q2 		$1.09M Buy
+8,333
New +$1.04M 0.01% 575
2019
Q3 		– Sell
-4,079
Closed -$1.44M – 516
2019
Q2 		$1.44M Buy
+4,079
New +$1.6M 0.02% 349
2018
Q3 		– Sell
-5,556
Closed -$2.04M – 524
2018
Q2 		$2.04M Sell
5,556
-1,111
-17% -$398K 0.02% 352
2018
Q1 		$2.24M Buy
+6,667
New +$2.24M 0.02% 340

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group's QTTB Position: Q3 2021 in Review

Alyeska Investment Group sold out of Q32 Bio (QTTB) in Q3 2021, closing a stake of 8,333 shares — an estimated $1.09M sold.

Alyeska Investment Group first reported a position in QTTB in Q1 2018 and held it in 4 quarters. The position peaked at $2.24M in Q1 2018. 119 funds tracked by Wall St. Rank hold QTTB as of Q3 2021.

  • Alyeska Investment Group reported no remaining Q32 Bio position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 8,333 Q32 Bio shares in Q3 2021, an estimated $1.09M.
  • Alyeska Investment Group first reported a position in Q32 Bio in Q1 2018 and held it in 4 quarters.
  • Alyeska Investment Group's Q32 Bio position peaked at $2.24M in Q1 2018.
  • 119 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.